Senti Biosciences, Inc. Board of Directors

Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer/CRC cells. In addition, the company develops Tumor-Associated Antigen and Protective Antigen Paired Discovery Platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. The company has a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd for the clinical development of SENTI-301A to treat solid tumors. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Dr. Timothy K. Lu M.D., Ph.D.

Dr. Timothy K. Lu M.D., Ph.D.

Co-Founder, CEO & Director

Dr. James J. Collins Ph.D.

Dr. James J. Collins Ph.D.

Scientific Co-Founder, Chairperson of Scientific Advisory Board & Independent Director

Ms. Dee Olomajeye Dragon

Ms. Dee Olomajeye Dragon

Vice President of People Strategy & Culture

Dr. Wilson Wong Ph.D.

Dr. Wilson Wong Ph.D.

Scientific Co-Founder & Member of Scientific Advisory Board

Dr. Kanya Rajangam M.D., Ph.D.

Dr. Kanya Rajangam M.D., Ph.D.

President, Head of Research & Development and Chief Medical Officer

Mr. Thomas P. Chung

Mr. Thomas P. Chung

Vice President of Strategic Finance & Corporate Development

Ms. Yvonne Li M.B.A.

Ms. Yvonne Li M.B.A.

Interim CFO, Treasurer & Principal Accounting Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.